Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-25-000102

Options or other derivatives

  • Director acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Scadden David Director 2025-06-06 Grant or award · Stock Option (right to buy) +37,500 37,500 D: show line 1 in the form
Loading xslF345X05/wk-form4_1749586749.xml…